ESMO Conference, Lugano
3 July 2008 - 3 July 2008
Switzerland
The European Society for Medical Oncology (ESMO) will hold a conference from 3 to 6 July in Lugano, Switzerland.
For the second time, cancer experts and patients will be gathering in Switzerland to discuss the latest advances in the treatment and prevention of diseases that affect millions of people worldwide. The four-day meeting will feature presentations on the most common tumour types plus educational sessions addressing key issues such as cancer and pregnancy, human papillomavirus vaccines, cancer stem cells and biomarkers.
New data on cancer prevention, treatment and survival will be presented in poster symposia and other sessions, where highlights include:
- a study showing how changes in tumour cell count can identify which prostate cancer patients are benefitting from treatment;
- a large study of male breast cancer; and
- an analysis of data comparing treatments for aggressive non-Hodgkins lymphoma.
On the opening day of the conference, a symposium hosted by the European School of Oncology (ESO) will focus on the important topic of treating breast cancer in young women, followed by a keynote lecture on helping patients who survive cancer.
Over the following days, world leading experts will present the most recent updates on lung, prostate, colorectal, breast, head and neck cancers and brain tumours.
Along with the scientific conference, ESMO will also be running a patient seminar, which represents a vital opportunity for cancer patients and families to interact and communicate with doctors and other patients about treatment opportunities as well as the psycho-social aspects related to the disease.For further information, please visit:
http://www.esmo.org/activities/ecluconference/(opens in new window)
For the second time, cancer experts and patients will be gathering in Switzerland to discuss the latest advances in the treatment and prevention of diseases that affect millions of people worldwide. The four-day meeting will feature presentations on the most common tumour types plus educational sessions addressing key issues such as cancer and pregnancy, human papillomavirus vaccines, cancer stem cells and biomarkers.
New data on cancer prevention, treatment and survival will be presented in poster symposia and other sessions, where highlights include:
- a study showing how changes in tumour cell count can identify which prostate cancer patients are benefitting from treatment;
- a large study of male breast cancer; and
- an analysis of data comparing treatments for aggressive non-Hodgkins lymphoma.
On the opening day of the conference, a symposium hosted by the European School of Oncology (ESO) will focus on the important topic of treating breast cancer in young women, followed by a keynote lecture on helping patients who survive cancer.
Over the following days, world leading experts will present the most recent updates on lung, prostate, colorectal, breast, head and neck cancers and brain tumours.
Along with the scientific conference, ESMO will also be running a patient seminar, which represents a vital opportunity for cancer patients and families to interact and communicate with doctors and other patients about treatment opportunities as well as the psycho-social aspects related to the disease.For further information, please visit:
http://www.esmo.org/activities/ecluconference/(opens in new window)